Sheen, Y., Cho, I., Choi, J., & Park, J. (2022). Co-treatment with Vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer: ALK5 inhibitor suppressed radiation induced metastasis. Radiology and Oncology, 56(2), 185–197. Retrieved from https://www.radioloncol.com/index.php/ro/article/view/3779